The EURAMED rocc-n-roll project has reached a significant milestone with the release of its Strategic Research Agenda (SRA) and roadmap, marking the culmination of a three-year collaborative effort. This initiative, a cornerstone of the SAMIRA action plan, brought together experts from diverse fields to advance medical applications of ionising radiation while prioritising patient safety and care.
Running from September 2020 to August 2023, EURAMED rocc-n-roll harnessed the collective expertise of professionals in radiation biology, medical physics and dosimetry, ethics, clinical expertise, regulatory and health policy, AI, and industry. The SRA and Roadmap are the result of extensive cross-disciplinary consultation with stakeholders in health, radiation protection, and digitisation. The documents that have been submitted to and are currently under evaluation of the European Commission provide an all-encompassing overview of current research, identifying gaps and essential focus areas for future European research endeavors.
The release of the SRA and roadmap is a pivotal moment, solidifying Europe’s position as a leader in healthcare technologies, ensuring equitable access to safe, high-quality personalised care for Europe’s citizens.
Read the SRA here.
Read the Roadmap here.
